Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2837PDF: 1020HTML: 5526 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1758PDF: 856HTML: 152 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4797PDF: 1571HTML: 2251Untitled: 219Untitled: 235Untitled: 239Untitled: 224Untitled: 227 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1299PDF: 893HTML: 322 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3376PDF: 1979HTML: 7480 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3748PDF: 1476HTML: 188 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2256PDF: 957HTML: 6795Figure 1: 177 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2437PDF: 1601HTML: 651 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1874PDF: 729HTML: 2119Untitled: 225Untitled: 158Untitled: 177Untitled: 161Untitled: 169Untitled: 184Untitled: 191 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4839PDF: 1797HTML: 2723Untitled: 227 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1437PDF: 835HTML: 1032Untitled: 190 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3337PDF: 1258HTML: 2210 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1670PDF: 1250HTML: 266 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3209PDF: 1856HTML: 3673 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2584PDF: 1221HTML: 11809 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1426PDF: 1437PDF: 1024HTML: 214 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
741PDF: 472HTML: 6273 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2224PDF: 1209HTML: 3875 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2896PDF: 1084HTML: 374Preferred Reviewers: 213 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3724PDF: 1247HTML: 3908Untitled: 230Untitled: 267 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1221PDF: 416HTML: 97 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3666PDF: 903HTML: 6722 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3404PDF: 1295HTML: 2230Fi.1 Gritti.Rambaldi: 210 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4155PDF: 1976HTML: 1775 -
SOLITARY PLASMACYTOMA
3921PDF: 2204HTML: 1243fIGURES 1,2: 227







